Volume 92, Issue 7 pp. 1297-1300
Coronary Artery Disease

Use of chronic total occlusion percutaneous coronary intervention techniques for treating acute vessel closure

Arslan Shaukat MD

Arslan Shaukat MD

Minneapolis Heart Institute, Abbott Northwestern Hospital and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota

Search for more papers by this author
Michael Mooney MD

Michael Mooney MD

Minneapolis Heart Institute, Abbott Northwestern Hospital and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota

Search for more papers by this author
M. Nicholas Burke MD

M. Nicholas Burke MD

Minneapolis Heart Institute, Abbott Northwestern Hospital and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota

Search for more papers by this author
Emmanouil S. Brilakis MD, PhD

Corresponding Author

Emmanouil S. Brilakis MD, PhD

Minneapolis Heart Institute, Abbott Northwestern Hospital and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota

Correspondence

Emmanouil S. Brilakis, MD, PhD, Minneapolis Heart Institute, Abbott Northwestern Hospital, 920 E 28th Street #300, Minneapolis, MN 55407.

Email: [email protected]

Search for more papers by this author
First published: 14 September 2018
Citations: 7

Abstract

Acute vessel closure due to dissection is a known complication of percutaneous coronary intervention and can be challenging to treat, especially if guidewire position is lost. Re-entering into the distal true lumen is commonly done during chronic total occlusion interventions, as part of antegrade dissection strategies. We report two cases of acute vessel closure and guidewire position loss in which the Stingray LP system was successfully used to advance a guidewire into the distal true lumen and recanalize the occluded vessel.

CONFLICT OF INTEREST

Dr. Shaukat: none.

Dr. Mooney: none.

Dr. Burke: none.

Dr. Brilakis: consulting/speaker honoraria from Abbott Vascular, ACIST, American Heart Association (associate editor Circulation), Amgen, Asahi, Cardiovascular Innovations Foundation (Board of Directors), CSI, Elsevier, GE Healthcare, Medicure, Medtronic, and Nitiloop; research support from Boston Scientific and Osprey. Shareholder: MHI Ventures. Board of Trustees: Society of Cardiovascular Angiography and Interventions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.